Detalhe da pesquisa
1.
Advances in the management of myeloma: an update.
Br J Nurs
; 32(17): S4-S12, 2023 Sep 21.
Artigo
Inglês
| MEDLINE | ID: mdl-37737854
2.
Integrating artificial intelligence into haematology training and practice: Opportunities, threats and proposed solutions.
Br J Haematol
; 198(5): 807-811, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35781249
3.
Marrow changes and reduced proliferative capacity of mesenchymal stromal cells from patients with "no-option" critical limb ischemia; observations on feasibility of the autologous approach from a clinical trial.
Cytotherapy
; 24(12): 1259-1267, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-35999133
4.
Treatment patterns and outcomes of unfit and elderly patients with Mantle cell lymphoma unfit for standard immunochemotherapy: A UK and Ireland analysis.
Br J Haematol
; 194(2): 365-377, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33959947
5.
Autologous bone marrow mesenchymal stromal cell therapy for "no-option" critical limb ischemia is limited by karyotype abnormalities.
Cytotherapy
; 22(6): 313-321, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32273232
6.
In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT.
Bone Marrow Transplant
; 59(4): 526-533, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38297040
7.
High myeloid-derived suppressor cell frequencies in the duodenum are associated with enteropathy associated T-cell lymphoma and its precursor lesions.
Br J Haematol
; 178(6): 988-991, 2017 09.
Artigo
Inglês
| MEDLINE | ID: mdl-27341082
8.
Serum protein and electrolyte imbalances are associated with chemotherapy induced neutropenia.
Heliyon
; 8(7): e09949, 2022 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-35865973
9.
TP53 Mutations Identified Using NGS Comprise the Overwhelming Majority of TP53 Disruptions in CLL: Results From a Multicentre Study.
Front Oncol
; 12: 909615, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35837095
10.
Targeted next-generation sequencing of familial platelet disorder with predisposition to acute myeloid leukaemia.
Br J Haematol
; 175(1): 161-3, 2016 10.
Artigo
Inglês
| MEDLINE | ID: mdl-26525156
11.
Keeping an Eye on Bisphosphonate Therapy in Myeloma: A Case Report of Ocular Inflammation Postzoledronic Acid Infusion.
Case Rep Hematol
; 2021: 6647277, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33628538
12.
A Phase 1b Study to Evaluate the Safety and Efficacy of Durvalumab in Combination With Tremelimumab or Danvatirsen in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Clin Lymphoma Myeloma Leuk
; 21(5): 309-317.e3, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33632668
13.
COVID-19 in adults: test menu for hospital blood science laboratories.
Ir J Med Sci
; 189(4): 1147-1152, 2020 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-32424603
14.
Recurrent clotted blood specimens: a sticky dilemma.
Br J Hosp Med (Lond)
; 84(12): 1, 2023 Dec 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38153018
15.
Risk adjusted therapy in chronic lymphocytic leukemia: a phase II cancer trials Ireland (CTRIAL-IE [ICORG 07-01]) study of fludarabine, cyclophosphamide, and rituximab therapy evaluating response adapted, abbreviated frontline therapy with FCR in non-del(17p) CLL.
Leuk Lymphoma
; 59(6): 1338-1347, 2018 06.
Artigo
Inglês
| MEDLINE | ID: mdl-28925785
16.
Tumour Lysis Syndrome and Partial Remission Occurring After Administration of a Test Dose of Obinutuzumab.
Eur J Case Rep Intern Med
; 4(1): 000516, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-30755907
17.
Molecular Profiling: A Case of ZBTB16-RARA Acute Promyelocytic Leukemia.
Case Rep Hematol
; 2017: 7657393, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28529810
18.
A novel molecular assay using hybridisation probes and melt curve analysis for CALR exon 9 mutation detection in myeloproliferative neoplasms.
J Clin Pathol
; 70(8): 662-668, 2017 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-28143941
19.
A Phase Ib Dose-finding Study of Panobinostat and Ruxolitinib in Myelofibrosis.
Hemasphere
; 6(8): e757, 2022 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-35935608
20.
CD38 expression level and pattern of expression remains a reliable and robust marker of progressive disease in chronic lymphocytic leukemia.
Leuk Lymphoma
; 47(11): 2371-9, 2006 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-17107912